543103727	543103727	CD	B-NP	O
|	|	NN	I-NP	O
PHMH	PHMH	NN	I-NP	O
|	|	NN	I-NP	O
94581787	94581787	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9350856	9350856	CD	B-NP	O
|	|	CC	I-NP	O
11/28/2006	11/28/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
FEVER	FEVER	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2006	10/20/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/16/2006	1/16/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
HAAPALA	HAAPALA	NNP	B-NP	O
,	,	,	O	O
DEAN	DEAN	NNP	B-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
chief	chief	JJ	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
questionable	questionable	JJ	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
recent	recent	JJ	I-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
8/24/06	8/24/06	CD	B-NP	O
status	status	NN	I-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
with	with	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
then	then	RB	B-ADVP	O
later	later	RBR	B-ADVP	O
on	on	IN	B-PP	O
cefepime	cefepime	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
Since	Since	IN	B-PP	O
then	then	RB	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
progressive	progressive	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
confusion	confusion	NN	I-NP	O
with	with	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
balancing	balance	VBG	B-VP	O
and	and	CC	I-VP	O
becoming	become	VBG	I-VP	O
lethargic	lethargic	JJ	B-ADJP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
prompted	prompt	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
11/8/06	11/8/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
received	receive	VBN	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
97.6	97.6	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
120/60	120/60	CD	B-NP	O
and	and	CC	I-NP	O
96	96	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
mildly	mildly	RB	B-ADJP	O
distended	distended	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
hypoactive	hypoactive	JJ	I-ADJP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
amputated	amputate	VBN	I-VP	O
of	of	IN	B-PP	O
metatarsals	metatarsal	NNS	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
distal	distal	JJ	I-NP	O
5-cm	5-cm	JJ	I-NP	O
area	area	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
erythematous	erythematous	JJ	I-NP	O
,	,	,	I-NP	O
warm	warm	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
pus	pus	NN	B-NP	O
muscle	muscle	NN	I-NP	O
and	and	CC	I-NP	O
fascia	fascia	NN	I-NP	O
exposed	expose	VBN	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
bone	bone	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
overt	overt	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
exposure	exposure	NN	B-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
or	or	CC	O	O
no	no	DT	B-NP	O
exposed	expose	VBN	I-NP	O
bone	bone	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
overt	overt	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
lab	lab	NN	I-NP	B-protein
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	B-protein
1.4	1.4	CD	I-NP	I-protein
and	and	CC	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
10.7	10.7	CD	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
37	37	CD	B-NP	O
of	of	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
show	show	VBP	B-VP	O
questionable	questionable	JJ	B-NP	O
right	right	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
LVH	LVH	NN	I-NP	B-protein
,	,	,	O	O
hypokinesis	hypokinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
MR.	MR.	NNP	I-NP	O
EKG	EKG	NNP	I-NP	O
was	be	VBD	B-VP	O
sinus	sinus	JJ	B-NP	O
and	and	CC	I-NP	O
mild	mild	JJ	I-NP	O
left	left	JJ	I-NP	O
axis	axis	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
this	this	DT	B-NP	O
open	open	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
5-8	5-8	CD	I-NP	O
cm	cm	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
erythematous	erythematous	JJ	B-NP	O
fascia	fascia	NN	I-NP	O
and	and	CC	I-NP	O
muscle	muscle	NN	I-NP	O
exposed	expose	VBN	B-VP	O
likely	likely	RB	B-ADVP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
pus	pus	NN	I-NP	O
drainage	drainage	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
erythema	erythema	NN	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
with	with	IN	B-PP	O
given	give	VBN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
pseudomonal	pseudomonal	JJ	B-NP	O
infection	infection	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
start	start	VB	I-VP	O
to	to	TO	I-VP	O
treat	treat	VB	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
Zosyn	Zosyn	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
culture	culture	NN	B-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
Staph	Staph	NNP	I-NP	O
,	,	,	I-NP	O
Pseudomonas	Pseudomonas	NNP	I-NP	O
and	and	CC	I-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
Zosyn	Zosyn	NN	I-NP	B-protein
,	,	,	O	O
so	so	IN	O	O
we	we	PRP	B-NP	O
changed	change	VBD	B-VP	O
to	to	TO	I-VP	O
ceftazidime	ceftazidime	VB	I-VP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
imipenem	imipenem	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
sensitivities	sensitivity	NNS	B-NP	O
.	.	.	O	O

Plastic	Plastic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
asked	ask	VBN	B-VP	O
for	for	IN	B-PP	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressing	dressing	NN	I-NP	O
and	and	CC	I-NP	O
MRI	MRI	NN	I-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
achieved	achieve	VBN	I-VP	O
and	and	CC	O	O
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
and	and	CC	I-NP	O
Plastic	Plastic	NN	I-NP	O
also	also	RB	B-ADVP	O
thinks	think	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
taken	take	VBN	I-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
lesion	lesion	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
imipenem	imipenem	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Kory	Kory	NNP	I-NP	O
Dengel	Dengel	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

Plastic	Plastic	JJ	B-ADJP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Plastic	Plastic	JJ	B-ADJP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
cream	cream	NN	I-NP	O
called	call	VBN	B-VP	O
Ethezyme	Ethezyme	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
apply	apply	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
and	and	CC	I-NP	O
upper	upper	JJ	I-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
daily	daily	JJ	B-NP	O
bandage	bandage	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
following	follow	VBG	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
last	last	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
shows	show	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
degenerative	degenerative	JJ	I-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
thoracic	thoracic	JJ	I-NP	O
spine	spine	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
and	and	CC	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
consolidations	consolidation	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
stable	stable	JJ	B-NP	O
moderate	moderate	JJ	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
and	and	CC	O	O
satisfactory	satisfactory	JJ	B-NP	O
positioning	positioning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
PICC	PICC	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	VBP	B-VP	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
on	on	IN	B-PP	O
exacerbation	exacerbation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
strict	strict	JJ	B-NP	B-protein
Ins	In	NNS	I-NP	I-protein
and	and	CC	I-NP	O
Outs	Out	NNS	I-NP	O
with	with	IN	B-PP	O
daily	daily	JJ	B-NP	O
weight	weight	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
fluid	fluid	JJ	I-NP	O
restricted	restricted	JJ	I-NP	O
diet	diet	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
tan	tan	NN	I-NP	O
1500	1500	CD	I-NP	O
mL	mL	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
antihypertensive	antihypertensive	JJ	B-NP	O
,	,	,	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
captopril	captopril	NN	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	I-VP	O
lisinopril	lisinopril	VB	I-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
BNP	BNP	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
a	a	DT	B-NP	O
Lasix	Lasix	NN	I-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
over	over	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
for	for	IN	B-PP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
and	and	CC	O	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
32	32	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
please	please	NN	I-NP	O
refer	refer	VBP	B-VP	O
to	to	TO	B-PP	O
GI	GI	NN	B-NP	O
for	for	IN	B-PP	O
details	detail	NNS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
cards	card	NNS	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
of	of	IN	B-PP	O
irregular	irregular	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
about	about	IN	B-PP	O
once	once	RB	B-NP	O
every	every	DT	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
about	about	RB	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
on	on	IN	B-PP	O
6/17/06	6/17/06	CD	B-NP	O
early	early	JJ	I-NP	O
morning	morning	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Gastroenterology	Gastroenterology	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
GI	GI	NN	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
whole	whole	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
6/17/06	6/17/06	CD	B-NP	O
,	,	,	O	O
early	early	JJ	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
huge	huge	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
blood	blood	NN	B-NP	O
clots	clot	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
witnessed	witness	VBN	I-VP	O
by	by	IN	B-PP	O
nursing	nursing	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
got	get	VBD	B-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
33	33	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
previous	previous	JJ	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
37	37	CD	B-NP	O
.	.	.	O	O

Due	Due	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	I-VP	O
stay	stay	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
more	more	JJR	I-NP	O
night	night	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
GI	GI	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
from	from	IN	B-PP	O
Hoag	Hoag	NNP	B-NP	O
F.ka	F.ka	NNP	I-NP	O
Health	Health	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Haisley	Haisley	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Cutwright	Cutwright	NNP	I-NP	O
reveals	reveal	VBZ	B-VP	O
that	that	IN	B-SBAR	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
actually	actually	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
diverticuli	diverticuli	NNS	B-NP	O
,	,	,	O	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
cecal	cecal	JJ	I-NP	O
AVM	AVM	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
actively	actively	RB	I-VP	O
bleeding	bleed	VBG	I-VP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Klase	Klase	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
one	one	CD	B-NP	O
more	more	JJR	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
labs	lab	NNS	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
actively	actively	RB	I-VP	O
bleeding	bleed	VBG	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
on	on	IN	B-PP	O
11/12/06	11/12/06	CD	B-NP	O
,	,	,	O	O
morning	morning	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
32	32	CD	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
8/16/05	8/16/05	CD	B-NP	O
,	,	,	O	O
morning	morning	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
33	33	CD	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Overnight	Overnight	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
slowly	slowly	RB	I-VP	O
dropped	drop	VBN	I-VP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
have	have	VBP	B-VP	O
elevated	elevate	VBN	I-VP	O
creatinine	creatinine	NN	B-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
endocrine	endocrine	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
diabetic	diabetic	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
by	by	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
TSH	TSH	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
TFTs	TFT	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
lithium	lithium	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
Synthroid	Synthroid	NNP	B-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
glucose	glucose	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
ranging	range	VBG	I-VP	O
between	between	IN	B-PP	O
110	110	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
140	140	CD	B-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
regular	regular	JJ	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
of	of	IN	B-PP	O
a.c.	a.c.	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
before	before	IN	B-PP	O
meal	meal	JJ	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
covered	cover	VBN	I-VP	O
by	by	IN	B-PP	O
enough	enough	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
neurology	neurology	NN	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
talking	talk	VBG	B-VP	O
to	to	TO	B-PP	O
family	family	NN	B-NP	O
members	member	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
actually	actually	RB	B-ADVP	O
has	have	VBZ	B-VP	O
returned	return	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
original	original	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
hearing	hearing	NN	I-NP	O
problem	problem	NN	I-NP	O
,	,	,	O	O
so	so	IN	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
extremely	extremely	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
clearly	clearly	RB	B-ADVP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
have	have	VBP	B-VP	O
to	to	TO	I-VP	O
whisper	whisper	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ears	ear	NNS	I-NP	O
for	for	IN	B-SBAR	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
communication	communication	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
Parkinson	Parkinson	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
time	time	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
early	early	JJ	B-NP	O
morning	morning	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
waxing	wax	VBG	I-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
episodes	episode	NNS	B-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
starts	start	VBZ	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
confused	confuse	VBN	I-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
times	time	NNS	B-NP	O
and	and	CC	I-NP	O
day	day	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
place	place	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
after	after	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
become	become	VB	I-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
PPI	PPI	NNP	B-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
completed	complete	VBN	I-VP	O
his	his	PRP$	B-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
imipenem	imipenem	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Clarence	Clarence	NNP	I-NP	O
G	G	NNP	I-NP	O
Verge	Verge	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
clinic	clinic	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
689-344-1861	689-344-1861	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
following	follow	VBG	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebs	neb	NNS	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
h.	h.	NN	I-NP	O
and	and	CC	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
PR	PR	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
Celexa	Celexa	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
enoxaparin	enoxaparin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
,	,	,	O	O
Ethezyme	Ethezyme	NN	B-NP	O
one	one	CD	I-NP	O
applicator	applicator	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
wound	wound	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
edges	edge	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ulcerated	ulcerate	VBN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
and	and	CC	O	O
also	also	RB	B-ADVP	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
dressing	dress	VBG	I-VP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cream	cream	NN	I-NP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
imipenem	imipenem	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
8	8	CD	B-NP	O
h	h	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
Insulin	Insulin	NN	B-NP	B-protein
Regular	Regular	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
insulin	insulin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
give	give	VB	I-VP	O
any	any	DT	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
125	125	CD	B-NP	O
and	and	CC	I-NP	O
150	150	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
151	151	CD	B-NP	O
and	and	CC	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
given	give	VBN	I-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
201	201	CD	B-NP	O
and	and	CC	I-NP	O
250	250	CD	I-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
give	give	VB	I-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
251	251	CD	B-NP	O
and	and	CC	I-NP	O
300	300	CD	I-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
give	give	VB	I-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
301	301	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
350	350	CD	B-NP	I-DNA
,	,	,	O	O
should	should	MD	B-VP	O
give	give	VB	I-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
350	350	CD	B-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
give	give	VB	I-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
Imdur	Imdur	NNP	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
137	137	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
upset	upset	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
center	center	NN	I-NP	O
with	with	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
,	,	,	O	O
Zaroxolyn	Zaroxolyn	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zyprexa	Zyprexa	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	O	O
usually	usually	RB	B-VP	O
given	give	VBN	I-VP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
tablet	tablet	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
GI	GI	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
multivitamins	multivitamin	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12	12	CD	B-NP	O
h.	h.	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
DNR	DNR	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
CRP	CRP	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
defibrillation	defibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
intubation	intubation	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
imipenem	imipenem	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
completed	complete	VBN	B-NP	O
imipenem	imipenem	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
imipenem	imipenem	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
until	until	IN	B-PP	O
further	further	JJ	B-NP	O
notice	notice	NN	I-NP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Elmo	Elmo	NNP	I-NP	O
Birky	Birky	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
dressing	dress	VBG	I-VP	O
changes	change	NNS	B-NP	O
b.i.d.	b.i.d.	RB	B-ADJP	O
wet-to-dry	wet-to-dry	JJ	I-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
with	with	IN	B-PP	O
Ethezyme	Ethezyme	NN	B-NP	O
cream	cream	NN	I-NP	O
applied	apply	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
upper	upper	JJ	I-NP	O
edges	edge	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ulcerated	ulcerate	VBN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
checked	check	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
continued	continued	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
endocrine	endocrine	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
covered	cover	VBN	I-VP	O
by	by	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
covered	cover	VBN	B-VP	O
by	by	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
strict	strict	JJ	B-NP	O
ins	in	NNS	I-NP	O
and	and	CC	I-NP	O
outs	out	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-0903229	8-0903229	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MAZON	MAZON	NNP	B-NP	O
,	,	,	O	O
EMERY	EMERY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LAMPINEN	LAMPINEN	NN	B-NP	O
,	,	,	O	O
WALTER	WALTER	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0433576	0433576	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/12/06	11/12/06	CD	B-NP	O
\	\	NN	I-NP	O
.	.	.	O	O

br	br	NN	B-NP	O
&	&	CC	I-NP	O
.	.	.	O	O

br	br	NN	B-NP	O
\	\	NN	I-NP	O
:	:	:	O	O
11/12/06	11/12/06	CD	B-NP	O

